TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME), ...

Warrants Z were exercised resulting in the issuance of 2,435 new ordinary shares Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company ...

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment ...

Fintel reports that on June 17, 2025, Citigroup initiated coverage of NewAmsterdam Pharma Company N.V. (NasdaqGM:NAMS) with a ...

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME), ...

World leaders are dismantling global health programs and cutting back foreign aid. Will an extraordinary new medicine be able ...

According to the FIR, the complainant, Nilesh Shivprasad Singh, 40, a resident of Bhayandar (West), Thane, owns Kalyan Pharma ...

A new drug that gives almost complete protection against the virus was to be administered across Africa this year. Now, much ...

Hyderabad: Aurobindo Pharma Limited has announced the incorporation of a new wholly owned subsidiary in the United States ...

Brief of respondents Amarin Pharma, Inc., et al. in opposition filed. 06/02/2025: Reply of petitioners Hikma Pharmaceuticals USA Inc., et al. filed. (Distributed) 06/03/2025: DISTRIBUTED for ...